E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/17/2005 in the Prospect News PIPE Daily.

MedMira negotiates fixed conversion price on $3.2 million debenture placement

By Sheri Kasprzak

Atlanta, March 17 - MedMira Inc. said it has negotiated a fixed conversion price on $3.2 million in convertible debentures the company sold in August 2004.

The debentures will now be convertible into common shares at $1.12 each.

The conversion price had been set to equal the issue price of a future equity offering during the term of the debentures.

The other terms remain unchanged. The debentures are due Aug. 9, 2006 and bear interest at 15% annually.

MedMira, based in Halifax, N.S., develops and markets diagnostic tests for clinical laboratories.

On Thursday, MedMira's stock closed down $0.07 at $1.16.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.